This Week in Psychedelics - 8.6.21

ThisWeekinPsychedelics.png

Cannabis

  • Louisiana: Marijuana Decriminalization Law Takes Effect (NORML)

  • Missouri Probation Officers Are Sending People Back to Prison for Legally Using Medical Cannabis (MERRY JANE)

  • Trial to test if cannabis-based mouth spray can treat brain tumours (The Guardian)

  • Wyoming Marijuana Decriminalization And Medical Cannabis Initiatives Clear First 2022 Ballot Hurdle (Marijuana Moment)

  • Puerto Rico: Law Signed Protecting Medical Cannabis Patients from Employment Discrimination (NORML)

  • Arkansas Marijuana Activists Push For Legalization Ballot Initiative In 2022 (Marijuana Moment)

LSD

  • How the CIA used LSD to fight communism (Big Think)

Magic Mushrooms

  • Canadians Overwhelmingly Support Legal Access to Psilocybin-Assisted Therapy, Poll Reveals (Psilocybin Alpha)

  • COMPASS Pathways’ Psilocybin Patent Questioned By UK Patent Examiner (Psymposia)

  • Does This Medieval Fresco Show A Hallucinogenic Mushroom in the Garden of Eden? (Atlas Obscura)

  • Filament Health Is the First Public Company to Be Issued a Patent for Extraction of Natural Psilocybin (Psilocybin Alpha)

DMT

  • Enzymes Responsible for DMT Synthesis Coexist in Mammalian Brain Cells (Psychedelic Science Review)

  • PharmaDrug Forms Research Collaboration with Terasaki Institute for Novel Ocular Drug Formulation Program to Deliver DMT and Other Tryptamines to Treat Eye Disease (Psilocybin Alpha)

Ayahuasca

  • Addiction Treatment: Ayahuasca May Help Addicts Stop Abusing Alcohol and Drugs (Gilmore Health News)

Mescaline

  • Could Synthetic Mescaline Protect Declining Peyote Populations? (Chacruna)

Novel Psychoactive Substances

  • Deadly drug 25B-NBOH sold as powdered LSD in Melbourne, spike in Victorian hospitalisations (News.com.au)

Synthetic Cannabinoids

  • Lawsuit Filed Over Massachusetts Prisons’ Use of Faulty Drug Tests (Ganjapreneur)

Ketamine

  • With a nudge from AI, ketamine emerges as a potential rare disease treatment (STAT)

  • Ketamine May Combat Depression in Teens (Lucid News)

Miscellaneous

  • Usona Institute Breaks Ground for Global Center in Psychedelic Science (The Joplin Globe)

  • Drug deaths in England and Wales highest since 1993 (BBC)

  • The Story of “El Chapo” and Why the Drug War Will Never End (The Nation)

  • First-ever research centre for psychedelic drug therapy is opening in Australia (Mixmag)

  • Fireside Project Releases App for Psychedelic Peer Support (Psilocybin Alpha)

  • Modernization of Sacred Plant Medicine Traditions: At What Cost? (Psychedelics Today)

  • The Wonderful and Absurd Adventures of Rosemary Woodruff Leary: Fashion Icon, Fugitive, and Psychedelic Pioneer (Part One) (Chacruna)

  • Researchers Concerned About Whitewashing of Psychedelic-Assisted Mental Health Research (Mad in America)

  • Awakn Life Sciences Announces Its Second Location in the UK for “Awakn Clinics London,” Providing Treatment to the Largest City in the UK (Psilocybin Alpha)

  • Two Years After Oakland’s Psychedelic Decrim, What’s Been the Impact? (Filter)

  • Improving Y/Our Relationship with Psychedelics (Maps of the Mind)

  • Advancing the Psychedelic Renaissance (Reality Sandwich)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.